| Home Market Dynamics You and Market Sector Analysis Company Insights AI Investing About Contact Us Login |
| The price action of Health Care (XLV) sector is shaped by numerous forces, ranging from broad macroeconomic trends to company-specific performance and market structure. The overall sentiment for Health Care sector is very positive (overall 2.2, positive 2.8, negative -0.7) on 20251102. The forces of Price Level (2), Sentiment towards Fundamentals (1.8), Option Speculation (1.5), Broad Market Trend (0.3), and Sector Price Trend (-0.3) will drive up the price. The forces of Valuation Sentiment (-1), and Market Risk Prefrence (0) will drive down the price. 'Buy the dips' is the preferred trading strategy. Hourly SMA 20 trend line is likely to provide a support from any pullbacks. The swing to upside will be significant considering the high positive sentiment forces (2.8). The sentiment for Broad Market Trend is calculated based on SPY trend. The sentiment for Sector Price Trend is calculated based on XLV trend. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Prefrence is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. |
| Date | Attention | Average Attention | Price | Price Level | Change | SMA10 Trend | Market Sentiment | Trend Sentiment | Fundamentals | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-02 | 1% | 1.6% | 1.2 | -0.3 | 1.8 | 0 | ||||
| 2025-11-01 | 1% | 1.6% | 1.1 | -0.3 | 1.7 | 1.5 | ||||
| 2025-10-31 | 2% | 1.4% | 144.23 | 51 | -0.05% | 0.07% | 1.1 | -0.3 | 1.7 | 3.5 |
| 2025-10-30 | 3% | 1.3% | 144.3 | 52 | 0.17% | 0.14% | 1.1 | -0.4 | 2 | 4.9 |
| 2025-10-29 | 1% | 1% | 144.05 | 47 | -0.95% | 0.07% | 1.7 | -0.4 | 2.1 | -0.9 |
| 2025-10-28 | 2% | 1% | 145.44 | 74 | -0.65% | 0.21% | 1.8 | 0.2 | 2 | 5.2 |
| 2025-10-27 | 1% | 1% | 146.38 | 87 | 0.23% | 0.35% | 1.5 | 0.3 | 1.9 | 2.9 |
| 2025-10-26 | 1% | 1% | 1.3 | 0.4 | 2 | 1 | ||||
| 2025-10-25 | 0% | 0.9% | 1.3 | 0.4 | 2 | 0 | ||||
| 2025-10-24 | 1% | 0.9% | 146.05 | 79 | 0.01% | 0.28% | 1.4 | 0.4 | 2.2 | 0.9 |
| Both emotion scores and sentiment scores are calculated in a -10 - +10 scale. | The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| 1 (-7) As Congress Holds Up Obamacare Tax Credits, Insurers Hike Prices And Lose Customers The nation’s health insurers have hiked Obamacare prices to boost profits while bracing for losses of customers who cannot afford to buy more expensive coverage. (https://www.forbes.com/) Sun. Nov 2, 2025 | |
| 2 (7) Cigna’s Rebate-Free Pharmacy Model Holds Promise For Some Patients Cigna says it will “transition toward a new model where discounts negotiated with drug companies are available upfront to Americans buying their medications.” (https://www.forbes.com/) Sun. Nov 2, 2025 | |
| 3 (0) 1 Stock to Buy, 1 Stock to Sell This Week: Palantir, Pfizer Market Analysis by covering: S&P 500, SPDR® S&P 500® ETF Trust, Invesco QQQ Trust, Pfizer Inc. Read 's Market Analysis on Investing.com (https://www.investing.com/) Sun. Nov 2, 2025 | |
| 4 (8) ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat AbbVie beats earnings and raises guidance as Skyrizi and Rinvoq fuel growth, setting the stage for ABBV stock to hold $250 as a new floor (https://www.marketbeat.com/) Sat. Nov 1, 2025 | |
| 5 (-5) Pfizer sues to stop rival bid for drugmaker Metsera by Denmark's Novo Nordisk Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based Pfizer said Friday after markets closed that it was suing Metsera and a third drugmaker, Denmark’s Novo Nordisk, over a bid for Metsera that Novo announced Thursday. (https://finance.yahoo.com/) Sat. Nov 1, 2025 | |
About
Contact Us
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA